Upgrade to SI Premium - Free Trial

bioAffinity (BIAF)

15.27 +2.49 (19.48%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Form S-3 bioAffinity Technologies August 27, 2026 4:31 PM - SEC Filing Form 8-K bioAffinity Technologies For: Aug 20 August 20, 2026 8:31 AM - SEC Filing bioAffinity Technologies sets 1-for-15 reverse stock split Aug. 24 August 20, 2026 8:00 AM - StreetInsider bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 August 20, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Aug 18 August 18, 2026 8:31 AM - SEC Filing bioAffinity strikes federal distribution deal for CyPath Lung test August 18, 2026 8:01 AM - StreetInsider bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung August 18, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Aug 12 August 14, 2026 4:34 PM - SEC Filing bioAffinity Technologies closes $4M private placement via pre-funded warrants August 14, 2026 11:45 AM - StreetInsider WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 14, 2026 11:45 AM - PR NewsWire bioAffinity Technologies closes $4M private placement offering August 14, 2026 11:07 AM - StreetInsider bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 14, 2026 11:07 AM - BizWire bioAffinity Technologies prices $4M private placement on Nasdaq August 13, 2026 10:01 AM - StreetInsider WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 13, 2026 10:01 AM - PR NewsWire bioAffinity Technologies prices $4M private placement offering August 13, 2026 9:07 AM - StreetInsider bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules August 13, 2026 9:07 AM - BizWire Form 10-Q bioAffinity Technologies For: Jun 30 August 7, 2026 4:46 PM - SEC Filing bioAffinity (BIAF) Tops Q2 EPS by 146c August 7, 2026 8:51 AM - StreetInsider Form 8-K bioAffinity Technologies For: Aug 07 August 7, 2026 8:30 AM - SEC Filing bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung August 7, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Jul 30 July 31, 2026 5:15 PM - SEC Filing Form 8-K bioAffinity Technologies For: Jul 27 July 27, 2026 8:31 AM - SEC Filing bioAffinity publishes clinical framework for CyPath Lung nodule testing July 27, 2026 8:09 AM - StreetInsider bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung July 27, 2026 8:08 AM - BizWire Form 8-K bioAffinity Technologies For: Jul 22 July 22, 2026 8:30 AM - SEC Filing bioAffinity Technologies partners with Pictor to develop asthma and COPD tests July 22, 2026 8:11 AM - StreetInsider bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD July 22, 2026 8:08 AM - BizWire Form 8-K bioAffinity Technologies For: Jul 07 July 7, 2026 8:54 AM - SEC Filing bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year July 7, 2026 8:46 AM - StreetInsider bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues July 7, 2026 8:46 AM - BizWire Form 8-K bioAffinity Technologies For: Jun 30 June 30, 2026 5:19 PM - SEC Filing Q2 Investor Summit Virtual Live Wednesday June 24 June 23, 2026 3:41 PM - StreetInsider Q2 Investor Summit Virtual Live Wednesday June 24 June 23, 2026 3:41 PM - StreetInsider bioAffinity Technologies reports preclinical siRNA findings for skin cancer June 22, 2026 8:01 AM - StreetInsider bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells June 22, 2026 8:00 AM - BizWire Form 8-K bioAffinity Technologies For: Jun 16 June 18, 2026 5:07 PM - SEC Filing WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering June 18, 2026 2:55 PM - PR NewsWire bioAffinity Technologies closes $3.2M public offering June 18, 2026 1:17 PM - StreetInsider bioAffinity Technologies Announces Closing of $3.2 Million Offering June 18, 2026 1:16 PM - BizWire Form 424B4 bioAffinity Technologies June 18, 2026 9:26 AM - SEC Filing WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering June 17, 2026 10:42 AM - PR NewsWire bioAffinity Technologies prices $3.2 million public offering June 17, 2026 9:25 AM - StreetInsider bioAffinity Technologies Announces Pricing of $3.2 Million Offering June 17, 2026 9:25 AM - BizWire Form EFFECT bioAffinity Technologies June 17, 2026 6:04 AM - SEC Filing Form S-1/A bioAffinity Technologies June 16, 2026 4:00 PM - SEC Filing Form 8-K bioAffinity Technologies For: Jun 16 June 16, 2026 8:30 AM - SEC Filing BIOAFFINITY, Philips and 4DMEDICAL to host veteran lung health webinar June 16, 2026 8:06 AM - StreetInsider bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans June 16, 2026 8:06 AM - BizWire Form S-1 bioAffinity Technologies June 12, 2026 5:10 PM - SEC Filing Full Article List